Atlas Trials

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Clinical trial NCT03009201 · COMPLETED

Trial details

NCT number
NCT03009201
Sponsor
OHSU Knight Cancer Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced LeiomyosarcomaLocally Advanced LiposarcomaLocally Advanced Malignant Peripheral Nerve Sheath TumorLocally Advanced MyxofibrosarcomaLocally Advanced Undifferentiated Pleomorphic SarcomaMetastatic AngiosarcomaMetastatic Epithelioid SarcomaMetastatic FibrosarcomaMetastatic LiposarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor
Start date
2017-03-10
Primary completion
2019-10-08
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.